Shapiro M J
Arch Pathol Lab Med. 1984 Jun;108(6):473-4.
Postmortem examinations have been reimbursed under Part A of Medicare and as a reimbursable expense of the pathology department by Blue Cross. As diagnostic-related group reimbursement is implemented, hospitals are likely to cut costs by reducing the number of autopsies. Third-party payers representing the private sector will protect the interests of their subscribers or clients by excluding autopsies from coverage. To preserve the clearly demonstrable benefits that the autopsy has for the community, it will be necessary to include the autopsy as a cost of research and education. There are other costs that traditionally have been subsidized by insurance that must also be shifted to research and education. The challenge for the College of American Pathologists is to work with those with similar interests to develop funding separate and distinct from health insurance.
尸体解剖检查费用已由医疗保险A部分报销，并且蓝十字保险公司将其作为病理科的可报销费用。随着诊断相关组报销制度的实施，医院可能会通过减少尸检数量来削减成本。代表私营部门的第三方支付方将通过将尸检排除在保险范围之外，来保护其订阅者或客户的利益。为了保留尸检对社区明显可见的益处，有必要将尸检作为研究和教育成本纳入其中。传统上由保险补贴的其他成本也必须转移到研究和教育方面。美国病理学家学会面临的挑战是与有类似兴趣的各方合作，开发独立于健康保险的资金。
